Corneal Epithelial Development and the Role of Induced Pluripotent Stem Cells for Regeneration.

IF 2.1 4区 医学 Q4 CELL & TISSUE ENGINEERING Current stem cell research & therapy Pub Date : 2024-01-01 DOI:10.2174/1574888X18666230313094121
Komathi Selvarajah, Jun Jie Tan, Bakiah Shaharuddin
{"title":"Corneal Epithelial Development and the Role of Induced Pluripotent Stem Cells for Regeneration.","authors":"Komathi Selvarajah, Jun Jie Tan, Bakiah Shaharuddin","doi":"10.2174/1574888X18666230313094121","DOIUrl":null,"url":null,"abstract":"<p><p>Severe corneal disorders due to infective aetiologies, trauma, chemical injuries, and chronic cicatricial inflammations, are among vision-threatening pathologies leading to permanent corneal scarring. The whole cornea or lamellar corneal transplantation is often used as a last resort to restore vision. However, limited autologous tissue sources and potential adverse post-allotransplantation sequalae urge the need for more robust and strategic alternatives. Contemporary management using cultivated corneal epithelial transplantation has paved the way for utilizing stem cells as a regenerative potential. Humaninduced pluripotent stem cells (hiPSCs) can generate ectodermal progenitors and potentially be used for ocular surface regeneration. This review summarizes the process of corneal morphogenesis and the signaling pathways underlying the development of corneal epithelium, which is key to translating the maturation and differentiation process of hiPSCs in vitro. The current state of knowledge and methodology for driving efficient corneal epithelial cell differentiation from pluripotent stem cells are highlighted.</p>","PeriodicalId":10979,"journal":{"name":"Current stem cell research & therapy","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current stem cell research & therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1574888X18666230313094121","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Severe corneal disorders due to infective aetiologies, trauma, chemical injuries, and chronic cicatricial inflammations, are among vision-threatening pathologies leading to permanent corneal scarring. The whole cornea or lamellar corneal transplantation is often used as a last resort to restore vision. However, limited autologous tissue sources and potential adverse post-allotransplantation sequalae urge the need for more robust and strategic alternatives. Contemporary management using cultivated corneal epithelial transplantation has paved the way for utilizing stem cells as a regenerative potential. Humaninduced pluripotent stem cells (hiPSCs) can generate ectodermal progenitors and potentially be used for ocular surface regeneration. This review summarizes the process of corneal morphogenesis and the signaling pathways underlying the development of corneal epithelium, which is key to translating the maturation and differentiation process of hiPSCs in vitro. The current state of knowledge and methodology for driving efficient corneal epithelial cell differentiation from pluripotent stem cells are highlighted.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
角膜上皮发育和诱导多能干细胞在再生中的作用。
由感染性病因、外伤、化学损伤和慢性卡他性炎症引起的严重角膜病变,是导致永久性角膜瘢痕的威胁视力的病变之一。整个角膜或板层角膜移植通常是恢复视力的最后手段。然而,有限的自体组织来源和移植后潜在的不良后遗症促使人们需要更稳健、更有策略的替代方法。当代利用培养角膜上皮移植的管理方法为利用干细胞作为再生潜力铺平了道路。人类诱导多能干细胞(hiPSCs)可生成外胚层祖细胞,并有可能用于眼表再生。本综述总结了角膜形态发生过程和角膜上皮发育的信号通路,这是体外转化 hiPSCs 成熟和分化过程的关键。重点介绍了从多能干细胞驱动高效角膜上皮细胞分化的知识和方法现状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current stem cell research & therapy
Current stem cell research & therapy CELL & TISSUE ENGINEERING-CELL BIOLOGY
CiteScore
4.20
自引率
3.70%
发文量
197
审稿时长
>12 weeks
期刊介绍: Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research.
期刊最新文献
Deciphering the Immunomodulatory Pathways of Mesenchymal Stem Cells Insights into Suture Stem Cells: Distributions, Characteristics, and Applications A Study on the Role of miR-126 in the Repair Process after Spinal Cord Injury Magnesium Regulates the Migration and Differentiation of NPMSCs via the Integrin Signaling Pathway Salvianolic Acid B Accelerates Osteoporotic Fracture Healing via LncRNA-MALAT1/miR-155-5p/HIF1A Axis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1